BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 121 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q3 2018. The put-call ratio across all filers is 0.12 and the average weighting 0.6%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,079,000 | -43.6% | 13,758 | -45.6% | 0.00% | 0.0% |
| Q2 2022 | $3,686,000 | -22.7% | 25,297 | -37.1% | 0.00% | 0.0% |
| Q1 2022 | $4,770,000 | -16.2% | 40,231 | -2.6% | 0.00% | 0.0% |
| Q4 2021 | $5,690,000 | +146.2% | 41,299 | +148.3% | 0.00% | 0.0% |
| Q3 2021 | $2,311,000 | -13.3% | 16,633 | -39.5% | 0.00% | 0.0% |
| Q2 2021 | $2,667,000 | +17.0% | 27,474 | -17.6% | 0.00% | 0.0% |
| Q1 2021 | $2,279,000 | -32.7% | 33,340 | -15.6% | 0.00% | 0.0% |
| Q4 2020 | $3,385,000 | +192.1% | 39,493 | +121.6% | 0.00% | – |
| Q3 2020 | $1,159,000 | -22.2% | 17,822 | -12.5% | 0.00% | -100.0% |
| Q2 2020 | $1,489,000 | +2657.4% | 20,371 | +1185.2% | 0.00% | – |
| Q1 2020 | $54,000 | -90.0% | 1,585 | -84.1% | 0.00% | – |
| Q4 2019 | $542,000 | +774.2% | 9,949 | +578.6% | 0.00% | – |
| Q3 2019 | $62,000 | -70.8% | 1,466 | -69.7% | 0.00% | – |
| Q2 2019 | $212,000 | +1077.8% | 4,843 | +1264.2% | 0.00% | – |
| Q1 2019 | $18,000 | +50.0% | 355 | +13.4% | 0.00% | – |
| Q4 2018 | $12,000 | -63.6% | 313 | -65.5% | 0.00% | – |
| Q3 2018 | $33,000 | +230.0% | 908 | +227.8% | 0.00% | – |
| Q2 2018 | $10,000 | +150.0% | 277 | +87.2% | 0.00% | – |
| Q1 2018 | $4,000 | +100.0% | 148 | +94.7% | 0.00% | – |
| Q4 2017 | $2,000 | -94.1% | 76 | -91.8% | 0.00% | – |
| Q3 2017 | $34,000 | – | 925 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 896,844 | $123,594,000 | 67.92% |
| RP Management, LLC | 1,111,111 | $153,122,000 | 64.09% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,075,402 | $286,011,000 | 40.64% |
| ARS Investment Partners, LLC | 463,392 | $63,860,000 | 5.86% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 300,373 | $41,394,000 | 4.76% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 80,348 | $11,073,000 | 4.49% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 139,900 | $19,282,000 | 4.30% |
| Avidity Partners Management LP | 1,140,000 | $157,103,000 | 3.33% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 200,000 | $27,562,000 | 3.17% |
| Eventide Asset Management | 1,635,000 | $225,319,000 | 2.88% |